Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PlaqueTec Names Nick West CMO | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

PlaqueTec Names Nick West CMO

Aas principal investigator for both PlaqueTec’s recent clinical study and first-in-man study

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PlaqueTec, a Cambridge,UK-based company developing a biomarker-based approach to transform the understanding of coronary artery disease (CAD), the leading cause of death worldwide, has appointed Nick West as chief medical officer.

Dr. West is a consultant interventional cardiologist at Papworth Hospital, Cambridge, the UK’s largest specialist cardiothoracic unit. He has worked with PlaqueTec for a number of years as medical advisor, and was principal investigator for both PlaqueTec’s recent clinical study and the first-in-man study that preceded it.

“We are delighted that Nick has joined us as CMO,” said Tim Brears, chief executive officer, PlaqueTec. “He has significant experience in interventional cardiology and was integral to the development of PlaqueTec’s Liquid Biopsy System. He is an important addition to our team and will play a key role in the future development of our company.” 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters